{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:07:13Z","timestamp":1781644033371,"version":"3.54.5"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126750","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T18:04:53Z","timestamp":1431713093000},"page":"e0126750","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hypoxia-Induced Retinal Neovascularization in Zebrafish Embryos: A Potential Model of Retinopathy of Prematurity"],"prefix":"10.1371","volume":"10","author":[{"given":"Yu-Ching","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwu-Huey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1211\/0022357011778232","article-title":"Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416","volume":"53","author":"J Sukbuntherng","year":"2001","journal-title":"The Journal of pharmacy and pharmacology"},{"issue":"Pt 2","key":"ref2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/eye.1992.34","article-title":"Epidemiology of childhood blindness","volume":"6","author":"A Foster","year":"1992","journal-title":"Eye (London, England)"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12098-010-0279-7","article-title":"Retinopathy of prematurity","volume":"79","author":"D Chawla","year":"2012","journal-title":"The Indian Journal of Pediatrics"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","article-title":"The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study","volume":"116","author":"WV Good","year":"2005","journal-title":"Pediatrics"},{"issue":"Pt 2","key":"ref5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/eye.1992.32","article-title":"The premature retina: a model for the in vivo study of molecular genetics?","volume":"6","author":"JT Flynn","year":"1992","journal-title":"Eye (London, England)"},{"issue":"7070","key":"ref6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nature04482","article-title":"Retinal angiogenesis in development and disease","volume":"438","author":"RF Gariano","year":"2005","journal-title":"Nature (London)"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"J Chen","year":"2007","journal-title":"Angiogenesis"},{"issue":"Supplement 437","key":"ref8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2002.tb00157.x","article-title":"Pathogenesis of retinopathy of prematurity","volume":"91","author":"LEH Smith","year":"2002","journal-title":"Acta P\u00e6diatrica"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"The Committee for the Classification of Retinopathy of Prematurity. An International Classification of Retinopathy of Prematurity","volume":"102","year":"1984","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ophtha.2005.10.012","article-title":"Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals","volume":"113","author":"AP Adamis","year":"2006","journal-title":"Ophthalmology"},{"key":"ref11","first-page":"209","author":"N Ferrara","year":"2005"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)","volume":"26","author":"R Jorge","year":"2006","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07372.x","article-title":"Antiangiogenesis in haematological malignancies","volume":"143","author":"WW Li","year":"2008","journal-title":"British journal of haematology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0002-9440(10)64773-6","article-title":"Blockade of Vascular Endothelial Cell Growth Factor Receptor Signaling Is Sufficient to Completely Prevent Retinal Neovascularization","volume":"156","author":"H Ozaki","year":"2000","journal-title":"American Journal of Pathology"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"CW Pugh","year":"2003","journal-title":"Nature medicine"},{"issue":"4884","key":"ref16","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.2849206","article-title":"Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein","volume":"242","author":"MA Goldberg","year":"1988","journal-title":"Science"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation","volume":"107","author":"AC Epstein","year":"2001","journal-title":"Cell"},{"issue":"18","key":"ref18","doi-asserted-by":"crossref","first-page":"15911","DOI":"10.1074\/jbc.M300463200","article-title":"Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha","volume":"278","author":"Y Yuan","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1023\/A:1006728119549","article-title":"Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line","volume":"17","author":"H Liu X-","year":"1999","journal-title":"Clinical & experimental metastasis"},{"issue":"3","key":"ref20","first-page":"374","article-title":"Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo","volume":"71","author":"A Minchenko","year":"1994","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2006.06.037","article-title":"A new model of retinal photoreceptor cell degeneration induced by a chemical hypoxia-mimicking agent, cobalt chloride","volume":"1109","author":"A Hara","year":"2006","journal-title":"Brain research"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/01.ASN.0000074239.22357.06","article-title":"Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats","volume":"14","author":"M Matsumoto","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0301-4738.29505","article-title":"Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity","volume":"55","author":"PK Shah","year":"2007","journal-title":"Indian journal of ophthalmology"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10633-009-9180-y","article-title":"The development of the rat model of retinopathy of prematurity","volume":"120","author":"JM Barnett","year":"2010","journal-title":"Documenta ophthalmologica"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/02713683.2012.669003","article-title":"Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity","volume":"37","author":"R Rabinowitz","year":"2012","journal-title":"Current eye research"},{"key":"ref26","first-page":"57","article-title":"Rodent Models of Oxygen-Induced Retinopathy","author":"SE Yanni","year":"2008"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-213X-7-114","article-title":"Genetic determinants of hyaloid and retinal vasculature in zebrafish","volume":"7","author":"Y Alvarez","year":"2007","journal-title":"BMC developmental biology"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1371\/journal.pone.0002748","article-title":"Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy","volume":"3","author":"R Cao","year":"2008","journal-title":"PloS one"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ydbio.2014.07.024","article-title":"In vivo analysis of hyaloid vasculature morphogenesis in zebrafish: A role for the lens in maturation and maintenance of the hyaloid","volume":"394","author":"A Hartsock","year":"2014","journal-title":"Developmental biology"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"GJ Lieschke","year":"2007","journal-title":"Nature reviews Genetics"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt963","article-title":"Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation","volume":"22","author":"RT Peterson","year":"2004","journal-title":"Nat Biotechnol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006982-200204000-00002","article-title":"Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration","volume":"22","year":"2002","journal-title":"Retina"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"N Ferrara","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1634\/theoncologist.12-4-443","article-title":"Target practice: lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer","volume":"12","author":"M Los","year":"2007","journal-title":"The Oncologist"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/bjo.2009.178574","article-title":"Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review","volume":"95","author":"C Schmucker","year":"2011","journal-title":"The British journal of ophthalmology"},{"issue":"Suppl 1","key":"ref36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.5-suppl_1-11","article-title":"Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications","volume":"5","author":"LM Ellis","year":"2000","journal-title":"The oncologist"},{"issue":"20","key":"ref37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"D Martin","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1476-5381.2010.00871.x","article-title":"Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists","volume":"161","author":"JE Cannon","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"e7867","DOI":"10.1371\/journal.pone.0007867","article-title":"Selective inhibition of retinal angiogenesis by targeting PI3 kinase","volume":"4","author":"Y Alvarez","year":"2009","journal-title":"PloS one"},{"issue":"13","key":"ref40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1101\/gad.2042011","article-title":"Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism","volume":"25","author":"J Kim","year":"2011","journal-title":"Genes Dev"},{"issue":"7","key":"ref41","first-page":"2128","article-title":"Vascular changes and their mechanisms in the feline model of retinopathy of prematurity","volume":"33","author":"T Chan-Ling","year":"1992","journal-title":"Investigative ophthalmology & visual science"},{"issue":"1","key":"ref42","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"LE Smith","year":"1994","journal-title":"Investigative ophthalmology & visual science"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.2010.112","article-title":"The sweet side of HIF","volume":"78","author":"VH Haase","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1073\/pnas.0611206104","article-title":"Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting","volume":"104","author":"IB Lobov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Lepore D, Quinn GE, Molle F, Baldascino A, Orazi L, Sammartino M, et al. Intravitreal Bevacizumab versus Laser Treatment in Type 1 Retinopathy of Prematurity: Report on Fluorescein Angiographic Findings. Ophthalmology. 2014. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.ophtha.2014.05.015\" xlink:type=\"simple\">10.1016\/j.ophtha.2014.05.015<\/ext-link><\/comment> <object-id pub-id-type=\"pmid\">25001158<\/object-id>.","DOI":"10.1016\/j.ophtha.2014.05.015"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bjophthalmol-2012-302276","article-title":"Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity","volume":"97","author":"MA Castellanos","year":"2013","journal-title":"The British journal of ophthalmology"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"SJ Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity","volume":"38","author":"A Travassos","year":"2007","journal-title":"Ophthalmic surgery, lasers & imaging: the official journal of the International Society for Imaging in the Eye"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"HA Mintz-Hittner","year":"2008","journal-title":"Retina"},{"issue":"11","key":"ref50","first-page":"1727","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefe&apos;s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle","volume":"245","author":"EJ Chung","year":"2007","journal-title":"Ophthalmologie"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaapos.2009.10.011","article-title":"Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus \/","volume":"14","author":"JC Law","year":"2010","journal-title":"American Association for Pediatric Ophthalmology and Strabismus"},{"issue":"3 Suppl","key":"ref52","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","article-title":"Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity","volume":"28","author":"GA Lalwani","year":"2008","journal-title":"Retina"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2147\/DDDT.S55621","article-title":"Comparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery. Drug design","volume":"8","author":"G Chimote","year":"2014","journal-title":"development and therapy"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"CB Kimmel","year":"1995","journal-title":"Dev Dyn"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1964.sp007450","article-title":"Evidence for the Shift of Blood to the Nutritive Circulation during Reactive Hyperaemia","volume":"173","author":"KW Ballard","year":"1964","journal-title":"The Journal of physiology"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/nprot.2007.412","article-title":"The zebrafish\/tumor xenograft angiogenesis assay","volume":"2","author":"S Nicoli","year":"2007","journal-title":"Nat Protoc"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.aquatox.2012.11.007","article-title":"Cobalt-induced genotoxicity in male zebrafish (Danio rerio), with implications for reproduction and expression of DNA repair genes","volume":"126","author":"HC Reinardy","year":"2013","journal-title":"Aquatic toxicology"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/MCB.26.3.1142-1155.2006","article-title":"Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor 1-regulated zebra fish insulin-like growth factor binding protein 1 gene expression","volume":"26","author":"S Kajimura","year":"2006","journal-title":"Molecular and cellular biology"},{"issue":"16","key":"ref59","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1021\/es301758c","article-title":"Leptin-mediated modulation of steroidogenic gene expression in hypoxic zebrafish embryos: implications for the disruption of sex steroids","volume":"46","author":"RM Yu","year":"2012","journal-title":"Environmental science & technology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T06:56:49Z","timestamp":1599029809000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126750"}},"subtitle":[],"editor":[{"given":"Yuk Fai","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126750","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}